Health · ✓ 2 outlets

Trial Finds More Heart Events in Older Adults Who Stopped Statins, 12.7% vs 9.2%

A randomized trial called STREAM enrolled 1,880 adults aged 70 and older who had at least two chronic conditions and no known heart or artery disease. It was run at sites in Switzerland, the Netherlands and France and published in a leading medical journal, with results presented on Nov. 7. Over up to four years, 12.7% of those who stopped taking a statin had a heart attack, stroke or death, compared with 9.2% of those who kept taking it. Within the first two years heart attacks occurred in 1.4% of those who stopped versus 0.6% of those who continued. Some coverage rounds the 12.7% to 13%.

Doctors often ask whether older patients should keep taking cholesterol drugs they started decades ago. The trial was designed to test whether stopping is acceptable, and the answer depends on how the result is read: the American Heart Association summary describes stopping as generally safe at about two years, while the longer follow-up shows more events among those who stopped.

If you or a parent take a statin, do not stop on your own because of a headline. Ask the prescriber how this trial’s findings apply to your history, since the participants had no known heart disease.

Some experts read the two-year result as showing that stopping did not significantly raise heart attacks, strokes or deaths in this group, which supports reviewing medicines for older patients who take many pills.

Others point to the 12.7% versus 9.2% over up to four years and say a trial designed to show stopping was not much worse does not prove stopping carries no added risk.

Confirmed: the trial size and the two percentages. Not confirmed: that stopping is right for any individual. The trial excluded people with known heart disease. Watch for guideline groups’ responses over the coming weeks.

DailyDrop U.S. No. 39 · November 12, 2026

Read today’s front page →